128 related articles for article (PubMed ID: 26020569)
1. Preoperative serum chemokine (C-C motif) ligand 2 levels and prognosis in colorectal cancer.
Szczepanik AM; Siedlar M; Szura M; Kibil W; Brzuszkiewicz K; Brandt P; Kulig J
Pol Arch Med Wewn; 2015; 125(6):443-51. PubMed ID: 26020569
[TBL] [Abstract][Full Text] [Related]
2. C-C motif chemokine ligand (CCL) production in equine peripheral blood mononuclear cells identified by newly generated monoclonal antibodies.
Schnabel CL; Wemette M; Babasyan S; Freer H; Baldwin C; Wagner B
Vet Immunol Immunopathol; 2018 Oct; 204():28-39. PubMed ID: 30596378
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis.
Gui X; Qiu X; Tian Y; Xie M; Li H; Gao Y; Zhuang Y; Cao M; Ding H; Ding J; Zhang Y; Cai H
Int Immunopharmacol; 2019 May; 70():208-215. PubMed ID: 30851700
[TBL] [Abstract][Full Text] [Related]
4. Serial measurements of levels of the chemokines CCL2, CCL3 and CCL5 in serum of patients with acute ischaemic stroke.
Zaremba J; Ilkowski J; Losy J
Folia Neuropathol; 2006; 44(4):282-9. PubMed ID: 17183455
[TBL] [Abstract][Full Text] [Related]
5. Expression of CC chemokines CCL2, CCL5, and CCL11 is associated with duration of disease and complications in type-1 diabetes: a study on Iranian diabetic patients.
Jamali Z; Nazari M; Khoramdelazad H; Hakimizadeh E; Mahmoodi M; Karimabad MN; Hassanshahi G; Rezaeian M; Balaei P; Darakhshan S; Poor NM
Clin Lab; 2013; 59(9-10):993-1001. PubMed ID: 24273921
[TBL] [Abstract][Full Text] [Related]
6. CCL2, CCL3 and CCL5 chemokines in systemic sclerosis: the correlation with SSc clinical features and the effect of prostaglandin E1 treatment.
Bandinelli F; Del Rosso A; Gabrielli A; Giacomelli R; Bartoli F; Guiducci S; Matucci Cerinic M
Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S44-9. PubMed ID: 22691208
[TBL] [Abstract][Full Text] [Related]
7. Serum chemokine (CC motif) ligand 2 level as a diagnostic, predictive, and prognostic biomarker for prostate cancer.
Izumi K; Mizokami A; Lin HP; Ho HM; Iwamoto H; Maolake A; Natsagdorj A; Kitagawa Y; Kadono Y; Miyamoto H; Huang CK; Namiki M; Lin WJ
Oncotarget; 2016 Feb; 7(7):8389-98. PubMed ID: 26701731
[TBL] [Abstract][Full Text] [Related]
8. Significant association between high serum CCL5 levels and better disease-free survival of patients with early breast cancer.
Fujimoto Y; Inoue N; Morimoto K; Watanabe T; Hirota S; Imamura M; Matsushita Y; Katagiri T; Okamura H; Miyoshi Y
Cancer Sci; 2020 Jan; 111(1):209-218. PubMed ID: 31724785
[TBL] [Abstract][Full Text] [Related]
9. Serum VEGF-A and CCL5 levels as candidate biomarkers for efficacy and toxicity of regorafenib in patients with metastatic colorectal cancer.
Suenaga M; Mashima T; Kawata N; Wakatsuki T; Horiike Y; Matsusaka S; Dan S; Shinozaki E; Seimiya H; Mizunuma N; Yamaguchi K; Yamaguchi T
Oncotarget; 2016 Jun; 7(23):34811-23. PubMed ID: 27166185
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of serum CCL2 as prognostic biomarker in prostate cancer: a long-term follow-up study.
Iwamoto H; Izumi K; Nakagawa R; Toriumi R; Aoyama S; Shimada T; Kano H; Makino T; Kadomoto S; Yaegashi H; Kawaguchi S; Nohara T; Shigehara K; Kadono Y; Mizokami A
Jpn J Clin Oncol; 2022 Nov; 52(11):1337-1344. PubMed ID: 35726158
[TBL] [Abstract][Full Text] [Related]
11. C-C motif chemokine ligand 5 (CCL5) levels in gastric cancer patient sera predict occult peritoneal metastasis and a poorer prognosis.
Wang T; Wei Y; Tian L; Song H; Ma Y; Yao Q; Feng M; Wang Y; Gao M; Xue Y
Int J Surg; 2016 Aug; 32():136-42. PubMed ID: 27398691
[TBL] [Abstract][Full Text] [Related]
12. Chemokine profiles of interstitial pneumonia in patients with dermatomyositis: a case control study.
Oda K; Kotani T; Takeuchi T; Ishida T; Shoda T; Isoda K; Yoshida S; Nishimura Y; Makino S
Sci Rep; 2017 May; 7(1):1635. PubMed ID: 28487565
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma.
Sadeghi M; Lahdou I; Oweira H; Daniel V; Terness P; Schmidt J; Weiss KH; Longerich T; Schemmer P; Opelz G; Mehrabi A
Br J Cancer; 2015 Sep; 113(5):756-62. PubMed ID: 26270232
[TBL] [Abstract][Full Text] [Related]
14. Elevated Serum Levels of Monocyte Chemotactic Protein-1/Chemokine C-C Motif Ligand 2 are Linked to Disease Severity in Patients with Fibromyalgia Syndrome.
Zhao YC; Hu T; Chen Y; Du KT
Balkan Med J; 2019 Oct; 36(6):331-336. PubMed ID: 31486327
[TBL] [Abstract][Full Text] [Related]
15. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
16. The Diagnostic Significance of PDGF, EphA7, CCR5, and CCL5 Levels in Colorectal Cancer.
Üçüncü M; Serilmez M; Sarı M; Bademler S; Karabulut S
Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31505877
[TBL] [Abstract][Full Text] [Related]
17. Chemokine levels predict progressive liver disease in Down syndrome patients with transient abnormal myelopoiesis.
Kinjo T; Inoue H; Kusuda T; Fujiyoshi J; Ochiai M; Takahata Y; Honjo S; Koga Y; Hara T; Ohga S
Pediatr Neonatol; 2019 Aug; 60(4):382-388. PubMed ID: 30314728
[TBL] [Abstract][Full Text] [Related]
18. The relationship between chemokines CCL2, CCL3, and CCL4 with the tumor microenvironment and tumor-associated macrophage markers in colorectal cancer.
De la Fuente López M; Landskron G; Parada D; Dubois-Camacho K; Simian D; Martinez M; Romero D; Roa JC; Chahuán I; Gutiérrez R; Lopez-K F; Alvarez K; Kronberg U; López S; Sanguinetti A; Moreno N; Abedrapo M; González MJ; Quera R; Hermoso-R MA
Tumour Biol; 2018 Nov; 40(11):1010428318810059. PubMed ID: 30419802
[TBL] [Abstract][Full Text] [Related]
19. Significance of CCL2, CCL5 and CCR2 polymorphisms for adverse prognosis of Japanese encephalitis from an endemic population of India.
Chowdhury P; Khan SA
Sci Rep; 2017 Oct; 7(1):13716. PubMed ID: 29057937
[TBL] [Abstract][Full Text] [Related]
20. Transport of the Proinflammatory Chemokines C-C Motif Chemokine Ligand 2 (MCP-1) and C-C Motif Chemokine Ligand 5 (RANTES) across the Intact Mouse Blood-Brain Barrier Is Inhibited by Heparin and Eprodisate and Increased with Systemic Inflammation.
Quaranta DV; Weaver RR; Baumann KK; Fujimoto T; Williams LM; Kim HC; Logsdon AF; Omer M; Reed MJ; Banks WA; Erickson MA
J Pharmacol Exp Ther; 2023 Jan; 384(1):205-223. PubMed ID: 36310035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
